Franklin M Berger Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

Franklin M Berger is Director of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 778,353 shares of AVIR, which is worth approximately $2.86 Million. The most recent transaction as insider was on Nov 14, 2022, when has been sold 16,166 shares (Common Stock) at a price of $5.16 per share, resulting in proceeds of $83,416. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 778K

0% 3M change

0% 12M change

Total Value Held $2.86 Million

FRANKLIN M BERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2022	SELL Open market or private sale	$83,416 $5.16 p/Share	16,166 Reduced 2.03%	778,353 Common Stock
Nov 11 2022	SELL Open market or private sale	$131,325 $5.15 p/Share	25,500 Reduced 3.11%	794,519 Common Stock
Nov 03 2020	BUY Open market or private purchase	$999,984 $24.0 p/Share	41,666 Added 4.84%	820,019 Common Stock
Nov 03 2020	BUY Conversion of derivative security	-	759,606 Added 49.39%	778,353 Common Stock

Also insider at

EPIX

ESSA Pharma Inc. Healthcare

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

RAIN

Rain Therapeutics Inc. Healthcare

Director

BCEL

Atreca, Inc. Healthcare

Director

KZR

Kezar Life Sciences, Inc. Healthcare

Director

FMB